← Back to results

Mol Ther · 2016

Prevention of Muscle Wasting by CRISPR/Cas9-mediated Disruption of Myostatin In Vivo.

Molecular therapy : the journal of the American Society of Gene Therapy, 24(11): 1889-1891 PMID 27916995 DOI 10.1038/mt.2016.192

Open in PubMed ↗ Open via DOI ↗

Abstract

This article has no abstract in PubMed.

Cite